Genomic Approaches to Understanding Response and Resistance to Immunotherapy. - Wikidata - wikimedia - TriplyDB

Genomic Approaches to Understanding Response and Resistance to Immunotherapy.

Genomic Approaches to Understanding Response and Resistance to Immunotherapy.

http://www.wikidata.org/entity/Q38971262

about

Immunotherapy-associated autoimmune hemolytic anemia.Avelumab: combining immune checkpoint inhibition and antibody-dependent cytotoxicity.Molecular mechanisms of therapy resistance in solid tumors: chasing "moving" targets.Antigen Discovery and Therapeutic Targeting in Hematologic Malignancies.Correlating programmed death ligand 1 (PD-L1) expression, mismatch repair deficiency, and outcomes across tumor types: implications for immunotherapy.Novel regulators of PD-L1 expression in cancer: CMTM6 and CMTM4-a new avenue to enhance the therapeutic benefits of immune checkpoint inhibitors.Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer.A Comprehensive Immunologic Portrait of Triple-Negative Breast Cancer.Response to first line chemotherapy regimen is associated with efficacy of nivolumab in non-small-cell lung cancer.Development of Molecularly Targeted Agents and Immunotherapies in Glioblastoma: A Personalized Approach.Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics Future prospects of immune checkpoint blockade in cancer: from response prediction to overcoming resistance

P2860

Q37655534-8B112A96-E15D-4C89-9428-B38441C6D7A8 Q38920328-98946AB3-C42B-400F-9263-FF0684F8B612 Q39172297-DC2E068C-0002-495A-8E0F-9947FE8AE84B Q39243052-3C26996E-471C-46CC-939C-E06AF5F11228 Q45242086-B7ADAAFC-5B75-4331-8071-24513D58AC3D Q47098333-29485F2A-BC09-4408-B29B-43DF5E775C4A Q47111129-0FF3A8F8-8124-4BE2-AF0E-8BE0000ECAC6 Q48508520-BE15D75C-9AEE-4912-96FE-5370D0F9D442 Q51795706-290FF7A9-8AF7-4A1E-B005-37435108FCFF Q52365121-C0D036F6-B006-4DC1-9B86-F607AD897724 Q56594845-794711C9-1954-48FE-98CA-0192B83FC16F Q57167969-33A08164-CB37-452D-8339-33892E69DA5C

P2860

Genomic Approaches to Understanding Response and Resistance to Immunotherapy.

http://www.wikidata.org/entity/Q38971262

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Genomic Approaches to Understanding Response and Resistance to Immunotherapy.

@en

type

label

Genomic Approaches to Understanding Response and Resistance to Immunotherapy.

@en

prefLabel

Genomic Approaches to Understanding Response and Resistance to Immunotherapy.

@en

P1433

Q38971262-E90406A8-DE7C-4A91-8CA5-DFDD23072A59

P1476

Q38971262-A35C4F5B-5307-415F-8165-C2F210C3894A

P2093

Q38971262-057B1B1B-6510-4342-B3B8-698D87E61139

Q38971262-69A0EB52-4148-487B-A8F0-584B108D5B67

Q38971262-D632929B-0D42-4381-BD3E-53C276C4AAEE

P2860

Q38971262-05FE0366-505C-4B9B-BEBF-F08B162CF2B8

Q38971262-06F5F8CF-AE98-42F6-BCA0-77299BAC9DCA

Q38971262-0D2BD038-7948-490B-BEFF-869A37510CD8

Q38971262-0FF3681C-91C1-4DF8-857B-3104DD4848CD

Q38971262-14F93717-E271-4877-88DE-8682CB385AF0

Q38971262-23F46644-84C5-46E4-BA24-7A5F2CA8AD49

Q38971262-2AA6CB5B-DFA7-4CB9-AD1C-6F38D8B7CEAC

Q38971262-3613D539-A6C6-493B-BC00-BC6B7165001C

Q38971262-37605390-5611-4BE4-AE65-3DAB4359A506

Q38971262-39ACD269-A8E8-4DA8-8B8C-0D1F93110610

P304

Q38971262-56D561D7-789F-44AA-9529-007E7B9D301B

P31

Q38971262-8CF34C55-0951-4097-ACD3-2801EDFCCCF2

P356

Q38971262-48119FB5-0833-4E8C-8EA8-D23045B169D0

P407

Q38971262-03950EC2-B879-4C08-B92C-BA428ACE9071

P433

Q38971262-0FD46673-2009-48AA-9152-3F87D475434B

P478

Q38971262-BAD8E87B-A93D-4B90-8C7A-208D8B6D067C

P577

Q38971262-D8F84B11-22F5-44B8-96D9-30B98348B582

P698

Q38971262-37E492D8-76C6-44F6-9D15-AF9DB7A756FC

P932

Q38971262-75F0A03A-8176-4A0C-A11D-DA7B609B4AC2

P356

1078-0432.CCR-16-0066

P1433

Clinical Cancer Research

P1476

Genomic Approaches to Understanding Response and Resistance to Immunotherapy.

@en

P2093

David A Braun

http://www.w3.org/2001/XMLSchema#string

Eliezer M Van Allen

http://www.w3.org/2001/XMLSchema#string

Kelly P Burke

http://www.w3.org/2001/XMLSchema#string

P2860

Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method.

Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints.

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy

Immune checkpoint blockade: a common denominator approach to cancer therapy

The future of immune checkpoint therapy

P304

5642-5650

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-16-0066

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27698000

http://www.w3.org/2001/XMLSchema#string

P932

5135569

http://www.w3.org/2001/XMLSchema#string